Literature DB >> 9244238

Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs.

L Oltrona1, C M Speidel, D Recchia, S A Wickline, P R Eisenberg, D R Abendschein.   

Abstract

BACKGROUND: Exposure and upregulation of tissue factor in the wall of balloon-injured arteries may result in prolonged activation of coagulation contributing to restenosis. This study was designed to determine whether brief or more prolonged inhibition of tissue factor-mediated coagulation with tissue factor pathway inhibitor (TFPI) attenuates neointimal formation and luminal stenosis after balloon-induced arterial injury. METHODS AND
RESULTS: The carotid artery of minipigs fed an atherogenic diet was injured by repetitive balloon hyperinflations, a procedure that rapidly yields complex, plaque-like neointimal lesions and high-grade luminal stenosis. Recombinant TFPI (rTFPI) was administered intravenously beginning 15 minutes before balloon injury as either a high dose (0.5 mg/kg bolus and 100 microg x kg(-1) x min(-1)) for 3 hours (n=7) or 24 hours (n=6) or as a low dose (0.5 mg/kg and 25 microg x kg(-1) x min(-1)) for 24 hours (n=6). Control animals received intravenous heparin (100 U x kg(-1) x h(-1)) for 3 hours (n=6) or 24 hours (n=7) or aspirin (5 mg/kg P.O.) followed by heparin for 24 hours (n=7). Luminal stenosis, assessed histologically 4 weeks after injury, was 73+/-17% and 76+/-18% (mean+/-SEM) in animals that received rTFPI or heparin for 3 hours, respectively. In contrast, luminal stenosis was only 11+/-12% and 6+/-3% in pigs given high and low doses, respectively, of rTFPI for 24 hours compared with 46+/-22% in pigs given heparin for 24 hours and 40+/-19% in those given both heparin and aspirin (P<.0002).
CONCLUSIONS: Inhibition of tissue factor-mediated coagulation during the first 24 hours after deep arterial injury appears to be particularly effective for attenuating subsequent neointimal formation and stenosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9244238     DOI: 10.1161/01.cir.96.2.646

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries.

Authors:  P Zoldhelyi; Z Q Chen; H S Shelat; J M McNatt; J T Willerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Effect of short-term treatment with a monoclonal antibody to P-selectin on balloon catheter-induced: intimal hyperplasia, re-endothelialization, and attenuation of endothelial-dependent relaxation.

Authors:  D L Akers; D J Lefer; I L Chen; R G Wilkens; J Rice; H Aurora; T A Osgood; B Bedi; A N Tenaglia; A J Buda; P J Kadowitz; D B McNamara
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

3.  Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.

Authors:  Hsiu-Hui Chen; Cristina P Vicente; Li He; Douglas M Tollefsen; Tze-Chein Wun
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

4.  Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.

Authors:  Yung-Hsin Yeh; Shang-Hung Chang; Shin-Yu Chen; Chih-Jen Wen; Fu-Chan Wei; Rui Tang; Sam Achilefu; Tze-Chein Wun; Wei-Jan Chen
Journal:  Int J Cardiol       Date:  2017-04-06       Impact factor: 4.164

5.  Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?

Authors:  Gianluca Petrillo; Plinio Cirillo; Greta-Luana D'Ascoli; Fabio Maresca; Francesca Ziviello; Massimo Chiariello
Journal:  Curr Cardiol Rev       Date:  2010-11

6.  LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis.

Authors:  Chantal Kroone; Mariska Vos; Timo Rademakers; Marijke Kuijpers; Mark Hoogenboezem; Jaap van Buul; Johan W M Heemskerk; Wolfram Ruf; Astrid van Hylckama Vlieg; Henri H Versteeg; Marie-José Goumans; Carlie J M de Vries; Kondababu Kurakula
Journal:  Haematologica       Date:  2019-08-29       Impact factor: 9.941

7.  Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knock-in mice.

Authors:  Xiaolin He; Bing Han; Marco Mura; Li Li; Marcelo Cypel; Avery Soderman; Kristen Picha; Jing Yang; Mingyao Liu
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240

8.  An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.

Authors:  Woo Kon Jeong; Myung Ho Jeong; Kye Hun Kim; Sang Rok Lee; Ok Young Park; Ju Hyup Yum; Joo Han Kim; Won Kim; Jae Young Rhew; Youn Keun Ahn; Jeong Gwan Cho; Byoung Hee Ahn; Soon Pal Suh; Jong Chun Park; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

9.  Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.

Authors:  Christi M Terry; Ilya Zhuplatov; Yuxia He; Tze-Chein Wun; Seong-Eun Kim; Alfred K Cheung
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.